Network Meta-Analysis of Chinese Medicine Injections for the Intervention of Proteinuria in Diabetic Nephropathy
10.13359/j.cnki.gzxbtcm.2025.02.038
- VernacularTitle:中药注射液干预糖尿病肾病蛋白尿的网状Meta分析
- Author:
Ruyi NIE
1
;
Guoliang XIONG
;
Tian FU
;
Minqi PAN
Author Information
1. 广州中医药大学第四临床医学院,广东深圳 518033;深圳市中医院,广东深圳 518033
- Keywords:
diabetic nephropathy;
proteinuria;
Chinese medicine injection;
Dengzhan Xixin Injection;
Danshen Ligustrazine Injection;
Shenkang Injection;
Danhong Injection;
Meta-analysis
- From:
Journal of Guangzhou University of Traditional Chinese Medicine
2025;42(2):518-530
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the efficacy and safety of different Chinese medicine injections combined with angiotensin converting enzyme inhibitor/angiotensin Ⅱ receptor blocker(ACEI/ARB)in the treatment of proteinuria in diabetic nephropathy by using network Meta-analysis.Methods Clinical randomized controlled trials of Chinese medicine injection combined with ACEI/ARB for the treatment of proteinuria in early diabetic nephropathy were retrieved from the domestic databases such as China National Knowledge Infrastructure(CNKI),China Science and Technology Journal Database(VIP),Wanfang Data Knowledge Service Platform(Wanfang Data),and China Biology Medicine Disc(CBM),as well as from the oversea databases such as PubMed,EMbase,Web of Science,and Cochrane Library from database inception to October 2023.The Cochrane risk of bias tool ROB2.0 was used to evaluate the quality of the included literature,and traditional Meta-analysis and network Meta-analysis were performed by using R4.3.2 and Stata18.0.Results A total of 72 trials were included,involving 13 Chinese medicine injections,namely Huangqi Injection,Xuesaitong Injection,Puerarin Injection,Denzhan Xixin Injection,Breviscapin Injection,Danhong Injection,Xueshuantong Injection,Yinxingye Injection,Shuxuetong Injection,Yinxing Damo Injection,Danshen Injection,Shenkang Injection,and Danshen Ligustrazine Injection.The primary outcomes were urinary albumin excretion rate(UAER),24-hour urinary total protein(24hUTP),serum creatinine(SCr),and urine albumin-to-creatinine ratio(UACR).The results of traditional Meta-analysis showed that Chinese medicine injection combined with ACEI/ARB was more effective on reducing the levels of UAER[MD=-26.14,95%CI(-29.39,-22.89)],24hUTP[(MD=-0.22,95%CI(-0.27,-0.18)],SCr[MD=-0.34,95%CI(-0.50,-0.19)],and UACR[MD=-9.40,95%CI(-15.64,-3.16)]than ACEI/ARB alone,and the differences were all statistically significant(P<0.05).The results of network meta-analysis showed that the efficacy of Dengzhan Xixin Injection combined with ACEI/ARB was the optimum in terms of reducing UAER,Danshen Ligustrazine Injection combined with ACEI/ARB was the optimum in terms of decreasing 24hUTP,Shenkang Injection combined with ACEI/ARB was the optimum in terms of decreasing SCr,and Danhong Injection combined with ACEI/ARB had the best efficacy on improving UACR.Conclusion The efficacy and safety of Chinese medicine injection combined with ACEI/ARB in the treatment of proteinuria in early diabetic nephropathy are superior to those of ACEI/ARB alone in terms of lowering UAER,24hUTP,SCr,and UACR.However,due to the limitations of the quality and number of included literatures,the conclusions still need to be confirmed by more high-quality randomized controlled trials.
